Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lerner

Showing results (111-120 of 158) with videos related to

Pageof 16
Sort By:
The Journal of Urology|May 20, 2008
Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancerK Hendricksen, D Gleason, J M Young, et al.
Blood|August 15, 1995
Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapyS O'Brien, H Kantarjian, M Beran, et al.
Kidney International|October 1, 1980
Occupational exposure to lead: effects on renal functionC D Hong, I B Hanenson, S Lerner, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2020
Sadness, but not all negative emotions, heightens addictive substance useCharles A Dorison, Ke Wang, Vaughan W Rees, et al.
Annals of Internal Medicine|October 3, 1998
Infections in patients with chronic lymphocytic leukemia treated with fludarabineE J Anaissie, D P Kontoyiannis, S O'Brien, et al.
Leukemia & Lymphoma|April 11, 2003
Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemiaM J Keating, S O'Brien, D Kontoyiannis, et al.
Blood|January 3, 2001
Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcomeL Fayad, M J Keating, J M Reuben, et al.
Leukemia & Lymphoma|March 18, 2000
Prediction of prognosis following fludarabine used as secondary therapy for chronic lymphocytic leukemiaM J Keating, T L Smith, S Lerner, et al.
Cancer Research|October 27, 1998
Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemiaP Starostik, T Manshouri, S O'Brien, et al.
Leukemia|June 1, 1995
Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.
Pageof 16

Showing results (111-120 of 158) with videos related to

Sort By:
Pageof 16
The Journal of Urology|May 20, 2008
Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancerK Hendricksen, D Gleason, J M Young, et al.
Blood|August 15, 1995
Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapyS O'Brien, H Kantarjian, M Beran, et al.
Kidney International|October 1, 1980
Occupational exposure to lead: effects on renal functionC D Hong, I B Hanenson, S Lerner, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2020
Sadness, but not all negative emotions, heightens addictive substance useCharles A Dorison, Ke Wang, Vaughan W Rees, et al.
Annals of Internal Medicine|October 3, 1998
Infections in patients with chronic lymphocytic leukemia treated with fludarabineE J Anaissie, D P Kontoyiannis, S O'Brien, et al.
Leukemia & Lymphoma|April 11, 2003
Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemiaM J Keating, S O'Brien, D Kontoyiannis, et al.
Blood|January 3, 2001
Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcomeL Fayad, M J Keating, J M Reuben, et al.
Leukemia & Lymphoma|March 18, 2000
Prediction of prognosis following fludarabine used as secondary therapy for chronic lymphocytic leukemiaM J Keating, T L Smith, S Lerner, et al.
Cancer Research|October 27, 1998
Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemiaP Starostik, T Manshouri, S O'Brien, et al.
Leukemia|June 1, 1995
Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.
Pageof 16